The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of a DNA damage response deficiency (DDRD) assay and prognosis in early-stage esophageal adenocarcinoma.
Richard C. Turkington
No relevant relationships to disclose
Laura A. Hill
Employment or Leadership Position - Almac Diagnostics
Research Funding - Almac Diagnostics
Damian McManus
No relevant relationships to disclose
Stephen McQuaid
No relevant relationships to disclose
Ken Arthur
No relevant relationships to disclose
Jacqueline James
No relevant relationships to disclose
Manuel Salto-Tellez
No relevant relationships to disclose
Timothy S. Davison
Employment or Leadership Position - Almac Diagnostics
Research Funding - Almac Diagnostics
Claire Harrison
No relevant relationships to disclose
Colin Purcell
No relevant relationships to disclose
Richard H. Wilson
No relevant relationships to disclose
Thomas P. MacGregor
No relevant relationships to disclose
Ricky A. Sharma
No relevant relationships to disclose
Rebecca C. Fitzgerald
No relevant relationships to disclose
Patrick Johnston
Employment or Leadership Position - Almac Diagnostics
Paul D Harkin
Employment or Leadership Position - Almac Diagnostics
Stock Ownership - Almac Diagnostics
Martin McKinlay Eatock
No relevant relationships to disclose
Richard D. Kennedy
Employment or Leadership Position - Almac Diagnostics
Stock Ownership - Almac Diagnostics
Research Funding - Almac Diagnostics